Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
102.18 USD  -3.45 (-3.27%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Lightning Round: CarMax, Asbury Automotive & More
May 20, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category AES Corp , Penn National Gaming Inc/ , MGIC Investment Corp , and 14 more.
from CNBC.com News
Dividend Highlights/Lowlights for May 20
May 20, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Agnico-Eagle Mines (AEM) – up 6% Apple Inc. (AAPL) – up 3% AllianceBernstein... Read More
category vz , amgn , aem , and 10 more.
from Dividend Daily
NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
May 20, 2013
New York, May 20th (TradersHuddle.com) - The NASDAQ 100 Index is flat trading at 0, which represents 0% versus its previous close. The index is mixed for the session with slightly less than 50% of its... Read More
from TradersHuddle.com
Reference Points for Amgen
May 20, 2013
New York, May 20th (TradersHuddle.com) - Amgen Inc. ( NASDAQ:AMGN ) closed the trading day at $105.63, near its 50 day moving average that is set at $103.20. Amgen's price action is just above this... Read More
from TradersHuddle.com
Week in Review: RuiYi Signs Up Shanghai’s Genor to Develop mAb in China
May 18, 2013
RuiYi Inc., a San Diego-Shanghai biotech, signed an exclusive license with Genor BioPharma of Shanghai to develop RuiYi’s lead molecule in China; RuiYi also enlisted CMC Biologics to develop a cell... Read More
from ChinaBio® Today
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013
from PR Newswire
How to Play the Building Momentum in Amgen
May 16, 2013
New York, May 16th (TradersHuddle.com) - Shares of Amgen Inc. ( NASDAQ:AMGN ) closed the trading session at $107.42 with its price action in a very tight range, given that calculated support is set at... Read More
from TradersHuddle.com
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 16, 2013
from Business Wire News Releases
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response Read More
from PR Newswire
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 15, 2013
from PR Newswire
Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
May 15, 2013
Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesperson told... Read More
from ChinaBio® Today
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
 Read More
category NYSE:MRK , Stocks to Buy , NYSE:PFE , and 3 more.
from InvestorPlace - Latest Headlines
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Below are the top biotechnology stocks on the NASDAQ in terms of earnings estimate for the next quarter. Biogen Idec (NASDAQ: BIIB ) is estimated to post earnings of $2.07 per share in the September... Read More
category Benzinga , Highest EPS Estimates , CELG , and 6 more.
from Latest Articles from Benzinga.com
Trading Idea: Is Amgen close to Support?
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of Amgen Inc. ( NASDAQ:AMGN ) are trading very close to calculated support at $103.85 with price action closing at just $106.89 and placing the stock... Read More
from TradersHuddle.com
Amgen (AMGN) - Daily Volume Review
May 14, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ... Read More
from AVAFIN
Amgen Is Close to the 50 Day Moving Average
May 13, 2013
New York, May 13th (TradersHuddle.com) - Amgen Inc. ( NASDAQ:AMGN ) closed the trading day at $106.72, near its 50 day moving average that is set at $101.8461. Amgen's price action is just above this... Read More
from TradersHuddle.com
RBCC Partner n3D Signs U.S. Distribution Agreement
May 13, 2013
from Business Wire News Releases
Strategy Behind Our Success, We Get in Early: PSX, AMGN, MPC and BAX
May 11, 2013
from Marketwired News Releases
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
The Week in Review: Sagent Buys Out China JV Partner for $25 Million
May 11, 2013
Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner’s 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to... Read More
from ChinaBio® Today
Ex-Div Reminder for Amgen (AMGN)
May 10, 2013
On 5/14/13, Amgen Inc (AMGN) will trade ex-dividend, for its quarterly dividend of $0.47, payable on 6/7/13. As a percentage of AMGN's recent stock price of $104.54, this dividend works out to... Read More
category Dividends
from Dividend Channel
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Amgen (NASDAQ: AMGN ) and Zhejiang Beta Pharma Co., Ltd. (Zhejiang Beta Pharma) today announced that the companies have signed an agreement to form a joint venture to commercialize Amgen's Vectibix®... Read More
category Contracts , Benzinga , AMGN , and 1 more.
from Latest Articles from Benzinga.com
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients Read More
from PR Newswire
Technical Bull Stock Alert: Amgen, Inc. (AMGN), Target 112
May 09, 2013
Bridgewater, MA -- (SBWIRE) -- 05/09/2013 -- The online StockConsultant latest screen has found a biotechnology medicines company Amgen, Inc. (NASDAQ:AMGN) stock with a 75% bullish overall report and... Read More
from SBWire - Latest Press Releases
Bull’s Eye Report: Amgen (AMGN)
May 09, 2013
 Read More
category NASDAQ:PCYC , NYSE:CVD , NASDAQ:AMGN
from InvestorPlace - Latest Headlines
How To Profit From The Next Wave Of Dividends
May 09, 2013
 Read More
category NYSE:AVP , NYSE:ABC , NYSE:AA , and 3 more.
from InvestorPlace - Latest Headlines
Zhejiang Beta Pharma Forms JV with Amgen
May 09, 2013
Zhejiang Beta Pharma and Amgen will form a joint venture to commercialize Amgen's Vectibix ® (panitumumab) in China. Vectibix is a treatment for colorectal cancer. In addition to being experienced with... Read More
from ChinaBio® Today
Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day
May 08, 2013
DailyFinance.com : U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the... Read More
category dish , agu , bbby , and 28 more.
from DailyFinance.com
Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Perrigo Co. (NASDAQ:PRGO), and Amgen Inc. (NASDAQ:AMGN) Added to Growing Stock Report's NASDAQ Decliners Watch List.
May 08, 2013
New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Perrigo Co. (NASDAQ:PRGO), and Amgen Inc.... Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here